Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 58,818 | 24,515 | 6,591 | 10,170 | 1,240 |
| Cost of Goods | 43,769 | 18,492 | 9,669 | 9,716 | 925 |
| Gross Profit | 15,049 | 6,023 | -3,078 | 454 | 315 |
| Operating Expenses | 29,353 | 27,309 | 22,921 | 26,262 | 10,573 |
| Operating Income | -13,535 | -20,794 | -25,330 | -25,092 | -9,333 |
| Interest Expense | 952 | -110 | 929 | 339 | 9 |
| Other Income | 280 | 644 | 1,148 | 758 | 393 |
| Pre-tax Income | -14,207 | -20,040 | -25,111 | -24,673 | -8,949 |
| Net Income Continuous | -14,207 | -20,040 | -25,111 | -24,673 | -8,949 |
| Net Income | $-14,207 | $-20,040 | $-25,111 | $-24,961 | $-8,949 |
| EPS Basic Total Ops | -0.28 | -0.42 | -0.60 | -0.91 | -1.12 |
| EPS Basic Continuous Ops | -0.28 | -0.42 | -0.60 | -0.90 | -1.12 |
| EPS Diluted Total Ops | -0.28 | -0.42 | -0.60 | -0.91 | -1.12 |
| EPS Diluted Continuous Ops | -0.28 | -0.42 | -0.60 | -0.90 | -1.12 |
| EBITDA(a) | $-9,816 | $-18,087 | $-19,502 | $-19,137 | $-8,451 |